首页 | 本学科首页   官方微博 | 高级检索  
     


A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
Authors:Deepa K. Krishnadas  Suzanne Shusterman  Fanqi Bai  Lisa Diller  Janice E. Sullivan  Alexandra C. Cheerva  Rani E. George  Kenneth G. Lucas
Affiliation:1. Department of Pediatrics, Hematology/Oncology, University of Louisville, 571 South Floyd Street, Suite 445, Louisville, KY, 40202, USA
2. Department of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute and Boston Children’s Hospital, Harvard Medical School, Dana 640E, 450 Brookline Ave, Boston, MA, 02215, USA
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号